Yunnan Botanee Bio-Technology Group Co.LTD

SZSE:300957 Stock Report

Market Cap: CN¥18.8b

Yunnan Botanee Bio-Technology GroupLTD Future Growth

Future criteria checks 4/6

Yunnan Botanee Bio-Technology GroupLTD is forecast to grow earnings and revenue by 30.6% and 13.9% per annum respectively. EPS is expected to grow by 29.9% per annum. Return on equity is forecast to be 14.8% in 3 years.

Key information

30.6%

Earnings growth rate

29.9%

EPS growth rate

Personal Products earnings growth25.6%
Revenue growth rate13.9%
Future return on equity14.8%
Analyst coverage

Good

Last updated26 Dec 2024

Recent future growth updates

Recent updates

Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Nov 02
Earnings Troubles May Signal Larger Issues for Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Shareholders

Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?

Oct 19
Is Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Trading At A 39% Discount?

The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Sep 27
The Market Lifts Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957) Shares 26% But It Can Do More

Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Sep 25
Is Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) A Risky Investment?

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

Jun 03
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Will Pay A Smaller Dividend Than Last Year

A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

May 24
A Look At The Fair Value Of Yunnan Botanee Bio-Technology Group Co.LTD (SZSE:300957)

Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 02
Yunnan Botanee Bio-Technology GroupLTD's (SZSE:300957) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

Feb 29
Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Has A Pretty Healthy Balance Sheet

Earnings and Revenue Growth Forecasts

SZSE:300957 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268,3891,2011,2111,37721
12/31/20257,4891,0389901,04022
12/31/20246,5327171,43290021
9/30/20246,108592117492N/A
6/30/20245,959791120467N/A
3/31/20245,756775342649N/A
12/31/20235,522757336610N/A
9/30/20235,5501,113554808N/A
6/30/20235,3321,106550843N/A
3/31/20235,0691,064434740N/A
1/1/20235,0141,051416769N/A
9/30/20224,8051,025532891N/A
6/30/20224,660993637999N/A
3/31/20224,323930601935N/A
1/1/20224,0228638821,153N/A
9/30/20213,332683518721N/A
6/30/20213,107648570702N/A
3/31/20212,825568438546N/A
12/31/20202,636544342431N/A
12/31/20191,944412454515N/A
12/31/20181,24026171102N/A
12/31/2017798154N/A202N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300957's forecast earnings growth (30.6% per year) is above the savings rate (2.8%).

Earnings vs Market: 300957's earnings (30.6% per year) are forecast to grow faster than the CN market (25.5% per year).

High Growth Earnings: 300957's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300957's revenue (13.9% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 300957's revenue (13.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300957's Return on Equity is forecast to be low in 3 years time (14.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 23:53
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yunnan Botanee Bio-Technology Group Co.LTD is covered by 42 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jian Jun ZouChasing Securities
Xiyue ZhangChasing Securities
Zhuonan XuChina International Capital Corporation Limited